Akèy › Twoub Mouvman
Etid klinik pou Twoub Mouvman ap rekrite nan Etazini
39 etid pou Twoub Mouvman ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Washington, DC7 etid
- Philadelphia, PA6 etid
- Boston, MA6 etid
- Pittsburgh, PA4 etid
- New York City, NY3 etid
- Baltimore, MD3 etid
- Columbus, OH3 etid
- Los Angeles, CA3 etid
Pa eta
- Arizona3 etid
- Florid5 etid
- Kalifòni7 etid
- Maryland9 etid
- Massachusetts6 etid
- New York5 etid
- Ohio5 etid
- Pennsylvania9 etid
- Texas4 etid
- Washington3 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Genetic Characterization of Movement Disorders and Dementias
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 120 · Tout sèks · Mizajou Oct 1, 2026 · NCT02014246Deep Brain Stimulation Therapy in Movement Disorders
Ap rekrite
Laj 18 a 100 · Tout sèks · Mizajou Sep 29, 2026 · NCT02119611A Study of SGT-212 Gene Therapy in Friedreich's Ataxia
Ap rekriteFaz 1
Laj 18 a 40 · Tout sèks · Mizajou Sep 29, 2026 · NCT07180355Phenotype/Genotype Correlations in Movement Disorders
Ap rekriteEtid obsèvasyon
Laj 2 a 100 · Tout sèks · Mizajou Sep 28, 2026 · NCT00018889The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease
Ap rekriteFaz 2
Laj 40 a 80 · Tout sèks · Mizajou Sep 28, 2026 · NCT07610369Human Movement Database
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
1 Month – 99 Years · Tout sèks · Mizajou Sep 28, 2026 · NCT00001252Botulinum Toxin for the Treatment of Involuntary Movement Disorders
Ap rekriteEtid obsèvasyon
Laj 2 a 100 · Tout sèks · Mizajou Sep 23, 2026 · NCT00001208Stimulating Specific Brain Areas (VOP/VIM) With Electricity to Improve Movement and Muscle Control
Ap rekrite
Laj 18 a 75 · Tout sèks · Mizajou Sep 18, 2026 · NCT07056361Natural History Protocol for Movement Disorders
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 2 a 100 · Tout sèks · Mizajou Sep 18, 2026 · NCT05413291Long-term Brain Stimulation of the Motor Ventral Thalamus (VOP/VIM) to Improve Motor Function
Ap rekriteVolontè an sante akeyi
Laj 18 a 80 · Tout sèks · Mizajou Sep 18, 2026 · NCT07056348Analysis of Cutaneous Phosphorylated Alpha-Synuclein to Identify Patients at Risk of Progressing From Essential Tremor to Parkinson's Disease
Ap rekriteEtid obsèvasyon
Laj 50 a 85 · Tout sèks · Mizajou Sep 18, 2026 · NCT07428447A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Sep 11, 2026 · NCT07804615Deep Brain Stimulation Surgery for Movement Disorders
Ap rekrite
Laj 18 a 99 · Tout sèks · Mizajou Sep 1, 2026 · NCT01581580Biofluid Research on Age-Related or Inherited Neurodegeneration
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT07798700Transplantation of Human iPS Cell-derived Dopaminergic Progenitors (CT1-DAP001) for Parkinson's Disease (Phase I/II)
Ap rekriteFaz 1
Laj 40 a 75 · Tout sèks · Mizajou Aug 17, 2026 · NCT06482268Psilocybin Therapy for Depression in Parkinson's Disease
Ap rekriteFaz 2
Laj 40 a 80 · Tout sèks · Mizajou Aug 7, 2026 · NCT06455293Circadian Adaptive DBS in Essential Tremor
Ap rekrite
Laj 21 a 89 · Tout sèks · Mizajou Jul 30, 2026 · NCT06635811Moderate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease
Ap rekrite
Laj 40 ak plis · Tout sèks · Mizajou Jul 29, 2026 · NCT06088355Motoneuron Recruitment and Motor Evoked Potential Up-Conditioning (MEP) in Spinal Cord Injury (SCI)
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Jul 29, 2026 · NCT07179822Neurophysiology of the Basal Ganglia, Thalamus, and Cerebellum in Patients With Movement Disorders
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 14, 2026 · NCT06848530Deutetrabenazine Treatment for Tardive Dyskinesia in Intellectual/Developmental Disabilities
Ap rekriteFaz 4
Laj 18 a 89 · Tout sèks · Mizajou Jul 6, 2026 · NCT06997198Stimulation-Based Modulation of Spinal and Cortical Sensory Pathways
Ap rekriteVolontè an sante akeyi
Laj 21 a 75 · Tout sèks · Mizajou Jun 4, 2026 · NCT07401186Cognitive Decline Following Deep Brain Stimulation
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou May 29, 2026 · NCT05822388Open Label Study for the Use of Low Intensity Focused Ultrasound for Essential Tremor
Ap rekriteFaz 1 bonè
Laj 18 a 90 · Tout sèks · Mizajou May 20, 2026 · NCT07599592A Randomized Study of SPK-10001 Gene Therapy in Participants With Huntington's Disease
Ap rekriteFaz 1/2
Laj 25 a 65 · Tout sèks · Mizajou May 5, 2026 · NCT06826612Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.